BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17178668)

  • 1. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
    Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
    Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'NESTROFT'--an effective screening test for beta thalassemia trait.
    Manglani M; Lokeshwar MR; Vani VG; Bhatia N; Mhaskar V
    Indian Pediatr; 1997 Aug; 34(8):702-7. PubMed ID: 9492398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
    Gomber S; Sanjeev ; Madan N
    J Trop Pediatr; 1997 Dec; 43(6):363-6. PubMed ID: 9476460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.
    Singh SP; Gupta SC
    Singapore Med J; 2008 Oct; 49(10):823-6. PubMed ID: 18946618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
    Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
    Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait?
    Mamtani M; Das K; Jawahirani A; Rughwani V; Kulkarni H
    J Med Screen; 2007; 14(4):169-73. PubMed ID: 18078560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the accuracy of the corpuscular fragility and mean corpuscular volume tests for the alpha-thalassemia 1 and beta-thalassemia traits.
    Sirichotiyakul S; Wanapirak C; Srisupundit K; Luewan S; Tongsong T
    Int J Gynaecol Obstet; 2009 Oct; 107(1):26-9. PubMed ID: 19591999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and molecular basis of beta-thalassemia in Isparta province and region.
    Tunç B; Cetin H; Gümrük F; Istanbullu B; Yavrucuoğlu H; Kurt U; Genç H
    Turk J Pediatr; 2002; 44(1):18-20. PubMed ID: 11858373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NESTROFF as a screening test for detection of Beta-thalassemia trait.
    Bobhate SK; Gaikwad ST; Bhaledrao T
    Indian J Pathol Microbiol; 2002 Jul; 45(3):265-7. PubMed ID: 12785163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S; Sirichotiyakul S; Srisupundit K; Tongsong T
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of MCV, MCH and HbA(2) in laboratory screening of thalassemia].
    Li LY; Li Q; Song LL; Jin WJ; Ma ZH; Yu YH; Zhong M
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):96-100. PubMed ID: 22455739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.
    Sirichotiyakul S; Tantipalakorn C; Sanguansermsri T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):347-50. PubMed ID: 15325851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of β-thalassemia carrier on 1495 couples in preconceptional period.
    Dell'Edera D; Epifania AA; Malvasi A; Pacella E; Tinelli A; Capalbo A; Lioi MB; Di Renzo G
    J Matern Fetal Neonatal Med; 2013 Mar; 26(5):445-8. PubMed ID: 23039078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
    Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
    Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for beta-thalassaemia carriers in Egypt: significance of the osmotic fragility test.
    El-Beshlawy A; Kaddah N; Moustafa A; Mouktar G; Youssry I
    East Mediterr Health J; 2007; 13(4):780-6. PubMed ID: 17955759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NESTROFT - A Valuable, Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi Population.
    Piplani S; Manan R; Lalit M; Manjari M; Bhasin T; Bawa J
    J Clin Diagn Res; 2013 Dec; 7(12):2784-687. PubMed ID: 24551637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
    Chow J; Phelan L; Bain BJ
    Am J Hematol; 2005 Jul; 79(3):198-201. PubMed ID: 15981230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.